Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 7 for:    pazopanib GIST
Previous Study | Return to List | Next Study

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) (PAZOGIST)

This study has been completed.
Information provided by (Responsible Party):
Centre Leon Berard Identifier:
First received: March 10, 2011
Last updated: February 24, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2016
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)